ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
BridgeBio Pharma Inc

BridgeBio Pharma Inc (BBIO)

35,99
-0,09
( -0,25% )
Aktualisiert: 20:42:06
Fortg. Diagramm

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
35,99
Gebot
35,99
Fragen
36,01
Volumen
1.030.172
35,31 Tagesbereich 36,49
21,62 52-Wochen-Bereich 41,04
Marktkapitalisierung
Handelsende
36,08
Handelsbeginn
36,13
Letzte Trade
187
@
35.99
Letzter Handelszeitpunkt
20:42:06
Finanzvolumen
US$ 36.888.358
VWAP
35,808
Durchschnittliches Volumen (3 Mio.)
2.392.218
Ausgegebene Aktien
188.989.802
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-10,52
Gewinn pro Aktie (EPS)
-3,4
Erlöse
9,3M
Nettogewinn
-643,2M

Über BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Derma... BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy. The company focus on genetic diseases because they exist at the intersection of high unmet patient need and tractable biology. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
BridgeBio Pharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BBIO. The last closing price for BridgeBio Pharma was US$36,08. Over the last year, BridgeBio Pharma shares have traded in a share price range of US$ 21,62 to US$ 41,04.

BridgeBio Pharma currently has 188.989.802 shares in issue. The market capitalisation of BridgeBio Pharma is US$6,82 billion. BridgeBio Pharma has a price to earnings ratio (PE ratio) of -10.52.

Option-Flow BridgeBio Pharma (BBIO)

Gesamtfluss

Bullisch

Nettoprämie

4k

Calls / Puts

200,00%

Käuf. / Verkä.

0,00%

OTM / ITM

200,00%

Sweeps

0,00%

BBIO Neueste Nachrichten

BridgeBio Announces Commercial Progress, Program Updates, and 2025 Milestones

- Remarkable early Attruby demand: 430 scripts written by 248 unique HCPs since FDA approval with broad uptake across academic centers and community centers in all patient types - Fully enrolled...

BridgeBio Pharma to Participate in the J.P. Morgan Healthcare Conference

PALO ALTO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases...

Acoramidis Receives Positive CHMP Opinion for Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of acoramidis in the EU based on positive results from the Phase 3 ATTRibute-CM study; final approval...

Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients

- Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR. Attruby has been shown to preserve the native function of TTR as a transport protein of...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.240.67132867132935.7536.2433.73340562934.85812931CS
47.8127.714691270428.1836.2427.23279595832.80988143CS
1211.7348.351195383324.2636.2421.72239221828.40870549CS
269.4535.606631499626.5436.2421.72207838827.34720691CS
52-1.24-3.3306473274237.2341.0421.62195852728.07618754CS
15626.09263.5353535359.944.324.98212704820.34775824CS
2603.6111.148857319332.3873.54.98172071724.54352604CS

BBIO - Frequently Asked Questions (FAQ)

What is the current BridgeBio Pharma share price?
The current share price of BridgeBio Pharma is US$ 35,99
How many BridgeBio Pharma shares are in issue?
BridgeBio Pharma has 188.989.802 shares in issue
What is the market cap of BridgeBio Pharma?
The market capitalisation of BridgeBio Pharma is USD 6,82B
What is the 1 year trading range for BridgeBio Pharma share price?
BridgeBio Pharma has traded in the range of US$ 21,62 to US$ 41,04 during the past year
What is the PE ratio of BridgeBio Pharma?
The price to earnings ratio of BridgeBio Pharma is -10,52
What is the cash to sales ratio of BridgeBio Pharma?
The cash to sales ratio of BridgeBio Pharma is 728,05
What is the reporting currency for BridgeBio Pharma?
BridgeBio Pharma reports financial results in USD
What is the latest annual turnover for BridgeBio Pharma?
The latest annual turnover of BridgeBio Pharma is USD 9,3M
What is the latest annual profit for BridgeBio Pharma?
The latest annual profit of BridgeBio Pharma is USD -643,2M
What is the registered address of BridgeBio Pharma?
The registered address for BridgeBio Pharma is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the BridgeBio Pharma website address?
The website address for BridgeBio Pharma is www.bridgebio.com
Which industry sector does BridgeBio Pharma operate in?
BridgeBio Pharma operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
BLBXBlackBoxStocks Inc
US$ 4,901
(190,00%)
183,53M
STAIScanTech AI Systems Inc
US$ 2,29
(55,78%)
45,74M
IPAImmunoPrecise Antibodies Ltd
US$ 0,6769
(37,30%)
284,12M
ASSTAsset Entities Inc
US$ 1,22
(35,56%)
114,46M
NTRBNutriband Inc
US$ 7,0095
(34,54%)
3,42M
STFSStar Fashion Culture Holdings Ltd
US$ 2,5309
(-81,27%)
28,42M
HEPAHepion Pharmaceuticals Inc
US$ 0,1327
(-58,76%)
28,09M
JUNSJupiter Neurosciences Inc
US$ 3,50
(-35,42%)
5,82M
STBXStarBox Group Holdings Ltd
US$ 0,64
(-34,47%)
1,3M
GODNGolden Star Acquisition Corporation
US$ 10,50
(-34,33%)
31,41k
IPAImmunoPrecise Antibodies Ltd
US$ 0,6769
(37,30%)
284,12M
BLBXBlackBoxStocks Inc
US$ 4,901
(190,00%)
183,53M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,29655
(24,13%)
163,28M
NVDANVIDIA Corporation
US$ 147,345
(4,63%)
152,09M
RGTIRigetti Computing Inc
US$ 13,6581
(-2,30%)
129,28M

BBIO Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock